Preview: Taysha Gene Therapies's Earnings

Taysha Gene Therapies (NASDAQ:TSHA) is set to give its latest quarterly earnings report on Wednesday, 2024-11-13. Here's what investors need to know before the announcement.

Analysts estimate that Taysha Gene Therapies will report an earnings per share (EPS) of $-0.09.

Investors in Taysha Gene Therapies are eagerly awaiting the company's announcement, hoping for news of surpassing estimates and positive guidance for the next quarter.

It's worth noting for new investors that stock prices can be heavily influenced by future projections rather than just past performance.

Overview of Past Earnings

In the previous earnings release, the company beat EPS by $0.08, leading to a 11.76% increase in the share price the following trading session.

Here's a look at Taysha Gene Therapies's past performance and the resulting price change:

Quarter

Q2 2024

Q1 2024

Q4 2023

Q3 2023

EPS Estimate

-0.17

-0.11

-0.11

-0.17

EPS Actual

-0.09

-0.10

0.92

-0.93

Price Change %

12.0%

21.0%

32.0%

26.0%

Market Performance of Taysha Gene Therapies's Stock

Shares of Taysha Gene Therapies were trading at $1.63 as of November 11. Over the last 52-week period, shares are up 22.92%. Given that these returns are generally positive, long-term shareholders should be satisfied going into this earnings release.

Analyst Observations about Taysha Gene Therapies

Understanding market sentiments and expectations within the industry is crucial for investors. This analysis delves into the latest insights on Taysha Gene ...